Human CD66a (CEACAM1) Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-Human CD66a (CEACAM1) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityHuman CD66a (CEACAM1)
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman, mouse, rat
Isotypen/a
FormatProtein A purified
Size0.1 mg, 0.2 mg
Concentrationn/a
ApplicationsELISA (EIA)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionCD66a is a member of the carcinoembryonic antigen (CEA) family, which belongs to the immunoglobulin superfamily. However, CD66a combines structural features of the immunoglobulin superfamily with functional properties of cadherins.The mechanism (s) by which CD66a transmits signals.are unclear. However, CD66a is phosphorylated on its cytoplasmic domain, largely on tyrosine with a lower level of phosphoserine, in neutrophils and colon cancer cells. While at least eight isoforms of CD66a derived from differential splicing have been described, only those isoforms with a long cytoplasmic tail can be phosphorylated on tyrosine. In addition, associated protein tyrosine kinase and phosphatase activities may be involved in CD66a signaling.
ImmunogenSource Note: Polyclonal CD66a antibody was produced from sera of rabbits immunized with C terminal antigenic determinants of CD66a.
Other Names[Rabbit Human CD66a (CEACAM1) purified; cd66a; cd-66a; cd-66; cd66; CEACAM1;; PAb], [CEACAM1; BGP; BGP1; BGP-1]
Gene, Accession #[CD66], Gene ID: 634, NCBI: NP_001020083.1, UniProt: P13688
Catalog #MBS551051
Price$375, $495
Order / More InfoHuman CD66a (CEACAM1) Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.